These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8231028

  • 1. Glomerular fibrinolytic activity in anti-GBM glomerulonephritis in rabbits.
    Malliaros J, Holdsworth SR, Wojta J, Erlich J, Tipping PG.
    Kidney Int; 1993 Sep; 44(3):557-64. PubMed ID: 8231028
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis.
    Kitching AR, Holdsworth SR, Ploplis VA, Plow EF, Collen D, Carmeliet P, Tipping PG.
    J Exp Med; 1997 Mar 03; 185(5):963-8. PubMed ID: 9120402
    [Abstract] [Full Text] [Related]

  • 3. Endogenous alpha2-antiplasmin does not enhance glomerular fibrin deposition or injury in glomerulonephritis.
    Kitching AR, Turner AL, O'Sullivan KM, Dewerchin M, Lijnen HR.
    J Thromb Haemost; 2003 Sep 03; 1(9):1992-9. PubMed ID: 12941042
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits.
    Tipping PG, Leong TW, Holdsworth SR.
    Lab Invest; 1991 Sep 03; 65(3):272-9. PubMed ID: 1890807
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.
    Holdsworth SR, Tipping PG.
    J Clin Invest; 1985 Oct 03; 76(4):1367-74. PubMed ID: 4056035
    [Abstract] [Full Text] [Related]

  • 7. Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis.
    Feng L, Tang WW, Loskutoff DJ, Wilson CB.
    J Am Soc Nephrol; 1993 May 03; 3(11):1753-64. PubMed ID: 8329670
    [Abstract] [Full Text] [Related]

  • 8. Glomerular macrophages express augmented procoagulant activity in experimental fibrin-related glomerulonephritis in rabbits.
    Tipping PG, Lowe MG, Holdsworth SR.
    J Clin Invest; 1988 Oct 03; 82(4):1253-9. PubMed ID: 3170746
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis.
    Kitching AR, Kong YZ, Huang XR, Davenport P, Edgtton KL, Carmeliet P, Holdsworth SR, Tipping PG.
    J Am Soc Nephrol; 2003 Jun 03; 14(6):1487-95. PubMed ID: 12761249
    [Abstract] [Full Text] [Related]

  • 10. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.
    Erlich JH, Holdsworth SR, Tipping PG.
    Am J Pathol; 1997 Mar 03; 150(3):873-80. PubMed ID: 9060825
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
    Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J, Carmeliet P, Loskutoff DJ, Stern DM.
    J Clin Invest; 1998 Sep 01; 102(5):919-28. PubMed ID: 9727060
    [Abstract] [Full Text] [Related]

  • 13. Deficiency of growth factor midkine exacerbates necrotizing glomerular injuries in progressive glomerulonephritis.
    Kojima H, Kosugi T, Sato W, Sato Y, Maeda K, Kato N, Kato K, Inaba S, Ishimoto T, Tsuboi N, Matsuo S, Maruyama S, Yuzawa Y, Kadomatsu K.
    Am J Pathol; 2013 Feb 01; 182(2):410-9. PubMed ID: 23201132
    [Abstract] [Full Text] [Related]

  • 14. Endogenous glucocorticoids modulate experimental anti-glomerular basement membrane glomerulonephritis.
    Leech M, Huang XR, Morand EF, Holdsworth SR.
    Clin Exp Immunol; 2000 Jan 01; 119(1):161-8. PubMed ID: 10606978
    [Abstract] [Full Text] [Related]

  • 15. Glomerular extracellular matrix accumulation in experimental anti-GBM Ab glomerulonephritis.
    Tang WW, Feng L, Loskutoff DJ, Wilson CB.
    Nephron; 2000 Jan 01; 84(1):40-8. PubMed ID: 10644907
    [Abstract] [Full Text] [Related]

  • 16. Macrophage-induced glomerular injury. Cell transfer studies in passive autologous antiglomerular basement membrane antibody-initiated experimental glomerulonephritis.
    Holdsworth SR, Neale TJ.
    Lab Invest; 1984 Aug 01; 51(2):172-80. PubMed ID: 6611452
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of steroids on leukocyte-mediated glomerulonephritis in the rabbit.
    Holdsworth SR, Bellomo R.
    Kidney Int; 1984 Aug 01; 26(2):162-9. PubMed ID: 6503135
    [Abstract] [Full Text] [Related]

  • 18. Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta.
    Hertig A, Berrou J, Allory Y, Breton L, Commo F, Costa De Beauregard MA, Carmeliet P, Rondeau E.
    FASEB J; 2003 Oct 01; 17(13):1904-6. PubMed ID: 12897066
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats.
    Huang XR, Tipping PG, Apostolopoulos J, Oettinger C, D'Souza M, Milton G, Holdsworth SR.
    Clin Exp Immunol; 1997 Jul 01; 109(1):134-42. PubMed ID: 9218836
    [Abstract] [Full Text] [Related]

  • 20. The fibrinolytic system: A new target for treatment of depression with psychedelics.
    Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S.
    Med Hypotheses; 2017 Mar 01; 100():46-53. PubMed ID: 28236848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.